Sangioza IVS: Financial statements 2019
CVR: 37894532
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Sangioza IVS (CVR 37894532) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -41,216 and a net result of DKK -41,240 compared with DKK -22,943 the year before. Equity in the 2019 report amounted to DKK -64,180.
- Gross Profit
- DKK -41,216
- Profit/Loss
- DKK -41,240
- Equity
- DKK -64,180
- Total Assets
- DKK 82
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -41 t. | -41 t. | -64 t. | - |
| 2018 | 430 | -22 t. | -23 t. | -23 t. | - |
| 2017 | 0 | 0 | 0 | 2 | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Sangioza IVS has published its annual report for 2018. Revenue came to DKK 430, and the net result was DKK -22,943.
About Sangioza IVS
Sangioza IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2016. The company has been dissolved on 29 June 2020. The company was registered under the industry Engroshandel med beklædning. The company was previously named Creavo IVS and Stone Designs IVS. In 2019, the company reported a gross profit of DKK -41,216 and a net result of DKK -41,240 compared with DKK -22,943 the year before. Equity in the 2019 report amounted to DKK -64,180.